Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
GlaxoSmithKline
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Safety and Efficacy of Once-Daily, Intranasal Administration of GW685698X Aqueous Nasal Spray 50mcg and 100mcg for 12 Weeks in Pediatric Subjects Ages 2 to \<12 Years with Perennial Allergic Rhinitis (PAR)
Age
2–12
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis of perennial allergic rhinitis.
You may not be if
Have significant concomitant medical conditions.
Use of corticosteroids or other allergy medications during the study.
Have abnormal ECG.
Have laboratory abnormality.
Have abnormal eye exam.
Clareo Health | Perennial Allergic Rhinitis Study In Pediatric Subjects
